NVT Logo (4).jpg
Industry Survey Identifies Successful Biotech Clinical Trial Strategies
08. Mai 2023 20:36 ET | Novotech
SYDNEY, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO conducted a survey of global biotech professionals, in partnership with Citeline, on their...
NVT Logo (4).jpg
Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations
07. März 2023 01:35 ET | Novotech
SINGAPORE, March 07, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical-stage biotechs and to share the...
NVT Logo (4).jpg
Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends
03. März 2023 00:27 ET | Novotech
SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar with Endpoints...
NVT Logo (4).jpg
Novotech Acquires European CRO – Strengthens Global Operations
12. Januar 2023 01:34 ET | Novotech
SINGAPORE, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...